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suMMARy – Hypereosinophilic syndrome is a rare disorder of the hematopoietic system. The 
disease is characterized by continuously high number of eosinophils (>1.5x109/l) for more than six 
months. other possible causes of hypereosinophilia, such as allergic and parasitic diseases, mali-
gnant disease, Churg-strauss disease and infection should be eliminated. The most common mani-
festations of hypereosinophilic syndrome are pulmonary, skin, gastrointestinal, cardiac difficulties 
and neurologic lesions. Numerous neurologic lesions have been described, in particular of the cen-
tral and peripheral nervous systems. Review of the literature revealed the following to have been 
recorded so far: mononeuritis multiplex, sensory polyneuropathy, radiculopathy, myalgia, myosi-
tis and perimyositis, neuropathy, ataxia, paraplegia, ophthalmologic abnormalities, optic neuritis, 
hemiplegia-hemiparesis, spasmodic quadriplegia, seizures, meningitis, cerebral infarction, organic 
psychosyndrome, other mental changes, stroke, temporal arteritis, leptomeningeal dissemination, 
memory deficits and dysarthria.
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Introduction 
Hypereosinophilic syndrome (Hes) is a rare and 
heterogeneous group of disorders defined as persistent 
marked blood eosinophilia (>1.5x109/l for more than 
six consecutive months) associated with evidence of 
eosinophil-induced organ damage, where other causes 
of hypereosinophilia such as allergic, parasitic, and ma-
lignant disorders have been excluded1-4. The prevalence 
is unknown, younger to middle-aged patients are most 
frequently affected, with a male predominance (4-9:1 
ratio)5. Hes is a disease of multifactorial genesis, from 
clonal tumorous proliferation to reactive changes. The 
myeloproliferative variant caused by interstitial dele-
tion in chromosome 4q12 and the lymphoproliferative 
variant associated with clonal proliferation of pheno-
typically abnormal t cells have been differentiated. 
An autosomal dominant familial form that has been 
mapped to chromosome 5q31, episodic form (gleich’s 
syndrome) and a clinically silent or benign form have 
also been described. in patients with the myeloprolif-
erative variant, well responding to imatinib therapy, 
fip1l1/pdgfRA (f/p) has been identified, being 
deemed an imatinib responsive Hes. The lymphop-
roliferative variant Hes (l-Hes) is characterized by 
a phenotypically distinct clonal t cell population in 
peripheral blood. Hypereosinophilia is a consequence 
of the increased production of the eosinophilopoietic 
cytokine, especially interleukin 5 (il-5). diagnosis is 
based on establishing a population of t cells with an 
aberrant phenotype, most often Cd3-Cd4+Cd8- in 
peripheral blood. However, around 50% of patients 
with Hes can be classified as neither myeloprolifera-
tive nor lymphoproliferative variant6-13. 
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Hes is treated by steroids, cytotoxic agents, im-
munomodulatory therapies, tyrosine kinase inhibi-
tors, monoclonal antibody therapy and bone marrow 
transplantation6-8. 
The organs affected by hypereosinophilia dif-
fer from case to case. Most commonly, these are the 
skin, heart, lungs, central and peripheral nervous sys-
tems. frequent manifestations are also hepato- and/
or splenomegaly, eosinophilic gastroenteritis, coagu-
lation disorders, etc.14-17. Neurologic symptomatology 
is nonspecific and varies; therefore we are presenting 
here the neurologic manifestations of Hes recorded 
so far.
Review of the Literature and Discussion
we performed systematic review of peer-reviewed 
publications identified through MedliNe databases 
(searched in May 2011). The search term was Hypere-
osinophil syndrome, and the search was limited to 
clinical trials and articles in english. The search was 
extended by reviewing bibliographies from pertinent 
original reports of data and review articles. unpub-
lished trials and data presented only in abstract form 
are not included.
literature reports damages to the central nervous 
system and peripheral nervous system. Authors very 






























optic ataxia, paralysis of visual fixation
Hemiplegia, spasmodic quadriplegia, seizures
Arterial occlusions of the retina, neurologic signs
Blurred vision on one or both eyes
Neurologic disturbances
Central nervous system dysfunction, encephalopathy characterized by behav-
ioral disturbances, motor neuron signs, peripheral neuropathy with sensory 






frequent neurologic signs, cerebral infarction, organic psychosyndrome
Abnormalities of the central and peripheral nervous system
Mononeuritis multiplex (acute myelino-axonal degeneration with endoneural 
edema), myalgia, axonal pattern of neuropathy
Bilateral papilledema
perimyositis, myositis, myalgia
peripheral neuropathy, mental changes
visual and cognitive disorders
paraplegia, dysuria
Ataxia, memory deficits, dysarthria
optic neuritis






leptomeningeal dissemination, intraventricular mass lesion
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often report numerous associated detrimental effects 
manifested by a number of symptoms such a monon-
euritis multiplex, sensory polyneuropathy, radiculopa-
thy, myalgia, myositis and perimyositis, neuropathy, 
ataxia, paraplegia, ophthalmologic abnormalities, 
optic neuritis, hemiplegia-hemiparesis, spasmodic 
quadriplegia, seizures, meningitis, cerebral infarction, 
organic psychosyndrome and other mental changes, 
memory deficits, dysarthria, etc. (table 1). 
Hes appears to be a very rare disease, manifest-
ed in damages to a number of organs. Most often af-
fected are the skin, heart, lungs, central and peripheral 
nervous systems, in as many as 50% of cases1. diffuse 
encephalopathy presents as altered behavior and cog-
nitive function, confusion, and memory loss. periph-
eral neuropathies present as symmetric or asymmetric 
sensory changes, pure motor deficits, or mixed sensory 
and motor complaints. stroke or transient ischemic 
episodes may result from cardiac difficulties and heart 
originating thrombus, but also from increased inclina-
tion to thrombosis1,2,38. it is the increased inclination to 
thrombosis in Hes that probably causes thrombosis of 
intracranial veins (longitudinal and/or lateral sinus).
Thus, hypereosinophilic syndrome may result in 
a number of neurologic signs. Therefore, in cases of 
neurologic signs with no clinically established cause, 
especially in younger people, the possible Hes should 
be considered.
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sažetak
NeuRoloŠKe MANifestACiJe HipeReoZiNofilNog siNdRoMA – pRegled liteRAtuRe
M. Titlić, K. Kodžoman i D. Lončar
Hipereozinofilni sindrom je rijetka bolest hematopoetskog sustava. Bolest je obilježena visokim brojem eozinofila 
(>1,5x109/l) duže od šest mjeseci, uz uvjet da su isključeni drugi mogući uzroci hipereozinofilije kao što su alergija i para-
zitne bolesti, maligne bolesti, Churg-straussova bolest i druge infekcijske bolesti. većina kliničkih manifestacija hipere-
ozinofilnog sindroma obuhvaća oštećenja pluća, kože, probavnog sustava, srčane poremećaje i neurološka oštećenja. opi-
sana su brojna neurološka oštećenja središnjeg i perifernog živčanog sustava. pretraživanjem literature nalaze se moguće 
neurološke manifestacije bolesti kao što su mononeuritis multiplex, senzorna polineuropatija, radikulopatija, mijalgija, mi-
ozitis i perimiozitis, neuropatija, ataksija, paraplegija, oftalmološki poremećaji, optički neuritis, hemiplegija-hemipareza, 
spastička tetraplegija, epileptični napadaji, meningitis, ishemijski moždani udar, psihoorganski sindrom i drugi mentalni 
poremećaji, temporalni arteritis, leptomeningealna diseminacija, poremećaji pamćenja i dizartrija. 
Ključne riječi: Manifestacije, neurološke; Hipereozinofilni sindrom

